Position in RCEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$101,598
+$8,728 QoQ
Shares Held
24,600
-2.0% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#27
of 73 holders
Holding Since
Mar 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RCEL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026IHT Wealth Management, LLC holds $8,979,059 across 9 Medical Devices names. RCEL ranks #7 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
49,959 | $4,533,279 | |
| 2 | SYK |
Stryker Corp
|
6,121 | $1,927,135 | |
| 3 | MDT |
Medtronic plc
|
20,583 | $1,610,208 | |
| 4 | EW |
Edwards Lifesciences Corp
|
3,021 | $273,279 | |
| 5 | GEHC |
GE HealthCare Technologies Inc.
|
3,671 | $234,980 | |
| 6 | TMDX |
TransMedics Group, Inc.
|
3,244 | $215,466 | |
| 7 | RCEL |
AVITA Medical, Inc.
This page
|
24,600 | $101,598 | |
| 8 | RXST |
RxSight, Inc.
|
10,000 | $48,200 |
All Filings in RCEL
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $101,598 | 24,600 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $92,870 | 25,100 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $86,595 | 25,100 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $132,093 | 25,850 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $147,591 | 27,900 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $223,036 | 27,400 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $346,880 | 27,100 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $301,232 | 28,100 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $178,992 | 22,600 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $309,386 | 22,550 | Shares | Sole | 2024-02-14 | |
| 2023-03-31 | $151,574 | 10,850 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||